JP2006523695A5 - - Google Patents

Download PDF

Info

Publication number
JP2006523695A5
JP2006523695A5 JP2006509780A JP2006509780A JP2006523695A5 JP 2006523695 A5 JP2006523695 A5 JP 2006523695A5 JP 2006509780 A JP2006509780 A JP 2006509780A JP 2006509780 A JP2006509780 A JP 2006509780A JP 2006523695 A5 JP2006523695 A5 JP 2006523695A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
amount
solution
aminoglycoside
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006509780A
Other languages
English (en)
Japanese (ja)
Other versions
JP4644659B2 (ja
JP2006523695A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/010698 external-priority patent/WO2004091666A1/en
Publication of JP2006523695A publication Critical patent/JP2006523695A/ja
Publication of JP2006523695A5 publication Critical patent/JP2006523695A5/ja
Application granted granted Critical
Publication of JP4644659B2 publication Critical patent/JP4644659B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2006509780A 2003-04-14 2004-04-07 注射に有用なピペラシリンおよびタゾバクタムを含有する組成物 Expired - Lifetime JP4644659B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46280803P 2003-04-14 2003-04-14
PCT/US2004/010698 WO2004091666A1 (en) 2003-04-14 2004-04-07 Compositions containing piperacillin and tazobactam useful for injection

Publications (3)

Publication Number Publication Date
JP2006523695A JP2006523695A (ja) 2006-10-19
JP2006523695A5 true JP2006523695A5 (cg-RX-API-DMAC7.html) 2007-06-07
JP4644659B2 JP4644659B2 (ja) 2011-03-02

Family

ID=32326726

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006509780A Expired - Lifetime JP4644659B2 (ja) 2003-04-14 2004-04-07 注射に有用なピペラシリンおよびタゾバクタムを含有する組成物

Country Status (34)

Country Link
US (3) US7498312B2 (cg-RX-API-DMAC7.html)
EP (1) EP1468697B1 (cg-RX-API-DMAC7.html)
JP (1) JP4644659B2 (cg-RX-API-DMAC7.html)
KR (1) KR100824554B1 (cg-RX-API-DMAC7.html)
CN (1) CN1802179B (cg-RX-API-DMAC7.html)
AR (1) AR043863A1 (cg-RX-API-DMAC7.html)
AT (1) ATE381947T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004229407B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0409450B8 (cg-RX-API-DMAC7.html)
CA (1) CA2464258C (cg-RX-API-DMAC7.html)
CH (1) CH695185A9 (cg-RX-API-DMAC7.html)
CL (1) CL2004000782A1 (cg-RX-API-DMAC7.html)
CO (1) CO5700796A2 (cg-RX-API-DMAC7.html)
CR (2) CR8035A (cg-RX-API-DMAC7.html)
CY (1) CY1108064T1 (cg-RX-API-DMAC7.html)
DE (1) DE602004010862T2 (cg-RX-API-DMAC7.html)
DK (1) DK1468697T3 (cg-RX-API-DMAC7.html)
EC (1) ECSP056100A (cg-RX-API-DMAC7.html)
ES (1) ES2298672T3 (cg-RX-API-DMAC7.html)
FR (1) FR2853547B1 (cg-RX-API-DMAC7.html)
GB (1) GB2400557B (cg-RX-API-DMAC7.html)
IL (1) IL171337A (cg-RX-API-DMAC7.html)
MX (1) MXPA05010996A (cg-RX-API-DMAC7.html)
MY (1) MY139099A (cg-RX-API-DMAC7.html)
NO (1) NO20054789L (cg-RX-API-DMAC7.html)
NZ (1) NZ543005A (cg-RX-API-DMAC7.html)
PL (1) PL1468697T3 (cg-RX-API-DMAC7.html)
PT (1) PT1468697E (cg-RX-API-DMAC7.html)
RU (2) RU2322980C2 (cg-RX-API-DMAC7.html)
SA (1) SA04250119B1 (cg-RX-API-DMAC7.html)
SI (1) SI1468697T1 (cg-RX-API-DMAC7.html)
TW (1) TWI308069B (cg-RX-API-DMAC7.html)
WO (1) WO2004091666A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200508315B (cg-RX-API-DMAC7.html)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1589901A4 (en) * 2002-12-20 2006-08-09 Generipharm Inc INTRAKUTANE INJECTION
PL1468697T3 (pl) * 2003-04-14 2008-05-30 Wyeth Corp Kompozycje zawierające piperacyklinę i tazobaktam przydatne do wstrzykiwań
JP2008516967A (ja) * 2004-10-14 2008-05-22 ワイス 乳酸ナトリウム希釈液中にピペラシリン、タゾバクタムおよびアミノカルボン酸を含む組成物
RS51506B (sr) * 2004-12-02 2011-06-30 Venus Remedies Limited H. O&R&D. Smeše za suzbijanje beta-laktamazom posredovane rezistencije na antibiotike upotrebom inhibitora beta-laktamaze, korisne za injekcije
ES2284318B1 (es) * 2005-04-13 2008-11-01 Labiana Development, S.L. Procedimiento de obtencion de una mezcla en polvo de una sal sodica de piperaciclina y tazobactama, util para su administracion por via inyectable.
ITMI20051630A1 (it) * 2005-09-02 2007-03-03 Acs Dobfar Spa Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi
CN101129381B (zh) * 2006-08-25 2012-02-01 天津和美生物技术有限公司 含β-内酰胺类抗生素和离子螯合剂的抗生素复方
CN102441169A (zh) * 2006-08-25 2012-05-09 天津和美生物技术有限公司 含β-内酰胺类抗生素和离子螯合剂的抗生素复方
CN101129382B (zh) 2006-08-25 2013-12-25 天津和美生物技术有限公司 含β-内酰胺类抗生素和缓冲组分的抗生素复方
CN1927201B (zh) * 2006-08-25 2011-06-01 天津和美生物技术有限公司 含哌拉西林的抗生素复方
CN102210679B (zh) * 2006-08-25 2013-03-13 天津和美生物技术有限公司 含哌拉西林的抗生素复方
CN101129383B (zh) * 2006-08-25 2014-04-02 天津和美生物技术有限公司 含氨基糖苷类抗生素的抗生素复方
CN101265263B (zh) * 2008-05-12 2010-06-02 海南百那医药发展有限公司 哌拉西林钠他唑巴坦钠复方注射剂的生产方法
JP5639471B2 (ja) * 2008-07-28 2014-12-10 惠三 山口 感染症治療効果増強剤
JP5852316B2 (ja) * 2010-03-30 2016-02-03 富山化学工業株式会社 ピペラシリン含有懸濁液の製造法
US20120046225A1 (en) 2010-07-19 2012-02-23 The Regents Of The University Of Colorado, A Body Corporate Stable glucagon formulations for the treatment of hypoglycemia
EA030662B1 (ru) 2010-11-25 2018-09-28 Аллекра Терапойтикс Гмбх β-ЛАКТАМОВЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ β-ЛАКТАМАЗЫ И ИХ ПРИМЕНЕНИЕ
WO2012122535A2 (en) 2011-03-10 2012-09-13 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of peptide drugs
JP6117811B2 (ja) 2011-10-31 2017-04-19 ゼリス ファーマシューティカルズ インコーポレイテッド 糖尿病を処置するための製剤
MY169816A (en) 2012-03-26 2019-05-16 Santen Pharmaceutical Co Ltd Ophthalmic solution comprising diquafosol
US9125805B2 (en) 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
US8476425B1 (en) * 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
KR101816798B1 (ko) * 2012-10-19 2018-01-10 주식회사유한양행 피페라실린 또는 그의 염, 타조박탐 또는 그의 염 및 덱사메타손 포스페이트 또는 그의 염을 포함하는 국소투여용 약학 조성물
US9018162B2 (en) 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
KR102329764B1 (ko) 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
US9499532B2 (en) 2014-02-07 2016-11-22 eXIthera Pharmaceuticals Inc. Therapeutic compounds and compositions
KR102428675B1 (ko) 2014-08-06 2022-08-02 엑스에리스 파머수티클스, 인크. 페이스트의 피내 및/또는 피하 주사를 위한 주사기, 키트, 및 방법
CN106714799A (zh) * 2014-10-08 2017-05-24 泽井制药株式会社 冷冻干燥制剂的制造方法
US9649364B2 (en) 2015-09-25 2017-05-16 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic formulations in aprotic polar solvents
US11590205B2 (en) 2015-09-25 2023-02-28 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
MX2017013433A (es) * 2016-03-31 2018-01-30 Wockhardt Ltd Composiciones antibacterianas.
WO2018025248A1 (en) * 2016-08-05 2018-02-08 Jodas Expoim Private Limited Edta injection and process for making the same
CN117085022A (zh) 2017-06-02 2023-11-21 Xeris药物公司 抗沉淀的小分子药物制剂
US11110054B2 (en) * 2018-05-09 2021-09-07 Slayback Pharma Llc Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate
CN112618486B (zh) * 2020-12-24 2023-07-18 浙江昂利康制药股份有限公司 一种注射用混悬油剂及其制备方法
CN113209030B (zh) * 2021-04-27 2023-04-25 海南通用康力制药有限公司 哌拉西林钠他唑巴坦钠无菌粉针剂的制备方法
IL309404A (en) * 2021-06-16 2024-02-01 Auregen Biotherapeutics Sa Gellan gum compositions and method for their preparation
WO2025253343A1 (en) * 2024-06-06 2025-12-11 Chandan Chopra AN ANTIBIOTIC COMPOSITION OF A PENICILLIN, A β-LACTAMASE INHIBITOR AND AN ION-CHELATING AGENT
CN119367287B (zh) * 2024-12-27 2025-03-28 成都硕德药业有限公司 一种重酒石酸去甲肾上腺素注射液及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4534977A (en) * 1981-03-26 1985-08-13 American Cyanamid Company Composition of matter comprising a low bulk density lyophilized preparation of Sodium Piperacillin
US4477452A (en) * 1981-03-26 1984-10-16 American Cyanamid Company Composition of matter comprising a lyophilized preparation of a penicillin derivative
US4562073A (en) * 1982-12-24 1985-12-31 Taiho Pharmaceutical Company Limited Penicillin derivatives
US5763480A (en) * 1994-02-14 1998-06-09 The Jewish Hospital Of St. Louis Inhibitors of cell-medicated disorders
US5580856A (en) 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
US6207661B1 (en) * 1999-02-22 2001-03-27 Baxter International Inc. Premixed formulation of piperacillin sodium and tazobactam sodium injection
EP1499341A4 (en) * 2002-04-18 2010-10-27 Univ Iowa Res Found METHOD FOR INHIBITING AND TREATING BACTERIAL BIOFILMS WITH METAL CHELATE IMAGES
US6900184B2 (en) * 2003-04-14 2005-05-31 Wyeth Holdings Corporation Compositions containing pipercillin and tazobactam useful for injection
AU2003230899A1 (en) * 2003-04-14 2004-11-26 Wyeth Holdings Corporation Compositions containing piperacillin and tazobactam useful for injection
PL1468697T3 (pl) 2003-04-14 2008-05-30 Wyeth Corp Kompozycje zawierające piperacyklinę i tazobaktam przydatne do wstrzykiwań

Similar Documents

Publication Publication Date Title
RU2005135135A (ru) Композиции, содержащие пиперациллин и тазобактам, применимые для инъекции
JP2013540104A (ja) 延長された保存安定性を有するペメトレキセドを含有する医薬組成物
RU2007119724A (ru) Композиции, содержащие эктинэсайдин и дисахарид
CN115990138A (zh) 包含高纯度坎格雷洛的药物制剂以及制备和使用它们的方法
BRPI0719096A2 (pt) Formulação parenteral estavel contendo uminibidor de rsv de uma estrutura de benzodiazepina
JP2024536768A5 (cg-RX-API-DMAC7.html)
JP2011137048A (ja) 新たな用途の薬学的調製物およびその調製物を製造するためのプロセス
WO2018003946A1 (ja) 凍結乾燥製剤の製造方法
CN108601730A (zh) 万古霉素的制剂
CN101433519B (zh) 阿奇霉素滴眼剂及其制备方法
TWI860656B (zh) 包含異唑啉衍生物之注射用製劑及其製造方法
TWI343261B (en) Injectable dosage form of flupirtine
CN102123714A (zh) 莰佛胺制剂及其制备
JP2005528351A5 (cg-RX-API-DMAC7.html)
CN118574603A (zh) 包含异𫫇唑啉衍生物的注射制剂及其制备方法
CN101422438A (zh) 一种不含辅料的复方二氯醋酸二异丙胺冻干制剂及制备工艺
TH72832A (th) สารผสมซึ่งมีพิเพอราซิลลินและตาโซแบคแตมที่มีประโยชน์สำหรับการฉีด
JP2026016486A5 (cg-RX-API-DMAC7.html)
JP2005200409A (ja) 注射剤
CN103037848A (zh) 氟吡汀的可注射剂型
CN1615845A (zh) 单位剂量形式的去甲基斑蝥酸或其衍生物粉针制剂及其制备方法
TH86014A (th) สารผสมที่ประกอบด้วยปิปเปอราซิลลินและทาโซแบคแทมที่มีประโยชน์สำหรับการฉีด
HK40025124A (en) Composition for injection
CN103083253A (zh) 对乙酰氨基酚冻干制剂及其制备方法
CN102048698A (zh) 一种硫酸链霉素白蛋白微球及制备方法